Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.
Saved in:
| Title: | Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply. |
|---|---|
| Authors: | Deanfield J; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK. Electronic address: john.e.deanfield@gmail.com., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Rasmussen S; Novo Nordisk, Søborg, Denmark., Stensen S; Novo Nordisk, Søborg, Denmark., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. |
| Source: | Lancet (London, England) [Lancet] 2026 Apr 25; Vol. 407 (10539), pp. 1601-1602. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42035774 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Deanfield+J%22">Deanfield J</searchLink>; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK. Electronic address: john.e.deanfield@gmail.com.<br /><searchLink fieldCode="AU" term="%22Emerson+SS%22">Emerson SS</searchLink>; Department of Biostatistics, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Rasmussen+S%22">Rasmussen S</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Stensen+S%22">Stensen S</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Lincoff+AM%22">Lincoff AM</searchLink>; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2026 Apr 25; Vol. 407 (10539), pp. 1601-1602. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42035774 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(26)00706-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1601 Titles: – TitleFull: Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Deanfield J – PersonEntity: Name: NameFull: Emerson SS – PersonEntity: Name: NameFull: Rasmussen S – PersonEntity: Name: NameFull: Stensen S – PersonEntity: Name: NameFull: Lincoff AM IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 04 Text: 2026 Apr 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 407 – Type: issue Value: 10539 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |